Document is current
Any future updates will be listed below
-
Authors
Hoffmann, Elgin http://orcid.org/0000-0002-9214-919X
Clasen, Kerstin
Frey, Bettina
Ehlers, Jakob
Behling, Felix
Skardelly, Marco
Bender, Benjamin
Schittenhelm, Jens
Reimold, Matthias
Tabatabai, Ghazaleh
Zips, Daniel
Eckert, Franziska
Paulsen, Frank
-
Funding
Funding for this research was provided by:
Medizinische Fakultät, Eberhard Karls Universität Tübingen (Junior Clinician Scientist Application No. 444-0-0)
- License Information
-
More Information
Article History
Received: 23 December 2020
Accepted: 28 May 2021
First Online: 25 June 2021
Declarations
:
: This study was approved by the local ethics committee Tuebingen, Germany (417/2017B02) and follows the principles of the Declaration of Helsinki. For this type of retrospective study formal consent is not required.
: Not applicable.
: GT reports personal fees (advisory board, speaker`s fees) from AbbVie, Bayer, Bristol-Myers-Squibb, Medac, Novocure, travel grants from Bristol-Myers-Squibb, educational and travel grants from Novocure, research grants from Roche Diagnostics, research and travel grants from Medac. The other authors declare no competing interests.
